  Tumors are believed to consist of a heterogeneous population of tumor cells
originating from rare cancer stem cells (CSCs). However, emerging evidences
show that tumor may also originate from non-CSCs. Here, we give evidences
supporting that the number of tumorigenic tumor cells is higher than the number
of CSCs and tumor can also derive from non-CSCs. First, we applied an idealized
mathematical model and theoretically calculated that non-CSCs could initiate
tumor if their proliferation potential was adequate. Next, we demonstrated by
experimental studies that 17.7%, 38.6% and 5.2% of tumor cells in murine B16
solid melanoma, H22 hepatoma and Lewis lung carcinoma, respectively, were
potentially tumorigenic. We propose that the rare CSCs, if exist, are not the
only origination of a tumor.
